Haemonetics Corp/ US4050241003 /
2024-11-12 10:10:00 PM | Chg. +1.98 | Volume | Bid2024-11-12 | Ask2024-11-12 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
93.38USD | +2.17% | 1.24 mill. Turnover: 79.82 mill. |
90.00Bid Size: 100 | 95.23Ask Size: 100 | 4.69 bill.USD | - | 40.25 |
Assets
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 253.3990 | 217.5590 | 258.4820 | 310.8850 | 311.3620 | ||||||
Intangible Assets | 133.1060 | 365.4830 | 310.2610 | 275.7710 | 406.1170 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 663.4710 | 1,126.3770 | 1,103.7030 | 1,165.1030 | 1,426.6880 | ||||||
Inventories | 270.2760 | 322.6140 | 293.0270 | 259.3790 | 317.2020 | ||||||
Accounts Receivable | 165.2070 | 127.5550 | 159.3760 | 179.1420 | 206.5620 | ||||||
Cash and Cash Equivalents | 137.3110 | 192.3050 | 259.4960 | 284.4660 | 178.8000 | ||||||
Current Assets | 603.6390 | 693.5460 | 756.0310 | 769.7220 | 768.9030 | ||||||
Total Assets | 1,267.1100 | 1,819.9230 | 1,859.7340 | 1,934.8250 | 2,195.5910 |
Liabilities
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 50.7300 | 50.2930 | 58.3710 | 63.9290 | 73.3580 | ||||||
Long-term debt | 305.5130 | 690.5920 | 559.4410 | 754.1020 | 797.5640 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 10.6000 | - | - | - | - | ||||||
Liabilities | 680.0010 | 1,088.2530 | 1,110.3100 | 1,116.8280 | 1,235.6320 | ||||||
Share Capital | .5030 | .5090 | .5110 | .5040 | .5080 | ||||||
Total Equity | 587.1090 | 731.6700 | 749.4240 | 817.9970 | 959.9590 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,267.1100 | 1,819.9230 | 1,859.7340 | 1,934.8250 | 2,195.5910 |
Income Statement
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 988.4790 | 870.4630 | 993.1960 | 1,168.6600 | 1,309.0550 | ||||||
Depreciation (total) | 110.2890 | 84.2870 | 97.7470 | 93.3070 | 97.2150 | ||||||
Operating Result | 103.3510 | 89.7470 | 80.7500 | 156.0330 | 164.8830 | ||||||
Interest Income | -16.1990 | -16.8340 | -17.1210 | -14.6300 | -13.0180 | ||||||
Income Before Taxes | 87.1520 | 72.9130 | 63.6290 | 141.4030 | 151.8650 | ||||||
Income Taxes | 10.6000 | -6.6000 | 20.3000 | 26 | 34.3000 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 76.5260 | 79.4690 | 43.3750 | 115.4010 | 117.5580 |
Per Share
Cash Flow
|
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
2024 US GAAP in mill. USD |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 158.2170 | 108.8050 | 172.2630 | 273.0580 | 181.7510 | ||||||
Cash Flow from Investing Activities | -57.1760 | -425.4420 | -86.3450 | -143.7880 | -322.3890 | ||||||
Cash Flow from Financing | -131.2080 | 367.4520 | -15.7490 | -100.3640 | 38.1570 | ||||||
Decrease / Increase in Cash | -32.0400 | 54.9940 | 67.1910 | 24.9700 | -105.6660 | ||||||
Employees | 3,004 | - | - | - | - |